Mesenchymal stem cells and platelet rich plasma in the treatment of premature ovarian insufficiency: a scoping review

Abstract Premature ovarian Insufficiency (POI) is characterized by amenorrhea, hypergonadotropic hypogonadism, estrogen deficiency, and reduced follicle counts leading to infertility under the age of 40. It occurs in 1 to 3% of women. Several therapeutic strategies have been explored in clinic for P...

Πλήρης περιγραφή

Λεπτομέρειες βιβλιογραφικής εγγραφής

Κύριοι συγγραφείς:	Jack Gemayel, Frédéric Harb, Farah Karam, Donna Tahan, Monique Younes, Yvanna Saliba, Diana Chaker, Ahmad Ibrahim, Albert Azar, Mustapha Chaaban, Alain Chebly, Khalil Akouch, Charbel Khalil
Μορφή:	Artigo
Γλώσσα:	Inglês
Έκδοση:	BMC 2025-09-01
Σειρά:	Contraception and Reproductive Medicine
Θέματα:	Premature ovarian insufficiency Mesenchymal stem cells Secretome Platelet rich plasma Stem cell therapy
Διαθέσιμο Online:	https://doi.org/10.1186/s40834-025-00368-1
Ετικέτες:	Προσθήκη ετικέτας Δεν υπάρχουν, Καταχωρήστε ετικέτα πρώτοι!